• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4593929)   Today's Articles (3453)   Subscriber (49325)
For: Grammatico S, Elia L, Peluso A, Pedace L, Matarazzo M, Vitale A, Rago A, Pane F, Foà R, Cimino G. Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia. Leuk Res 2009;33:e73-4. [DOI: 10.1016/j.leukres.2008.11.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2008] [Revised: 10/31/2008] [Accepted: 11/01/2008] [Indexed: 10/21/2022]
Number Cited by Other Article(s)
1
Böhm A, Herrmann H, Mitterbauer-Hohendanner G, Hauswirth AW, Rabitsch W, Mitterbauer M, Sperr WR, Kalhs P, Jäger U, Valent P. Stable non-transforming minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia after autologous transplantation: origin from neoplastic yet ‘pre-leukemic’ stem cells? Leuk Lymphoma 2011;52:842-8. [DOI: 10.3109/10428194.2011.557168] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA